Abstract |
Previous studies of Jak-STAT inhibitors have shown promise in treating kidney diseases. The activation of Jak-STAT components is important in cell fate determination in many cell types, including bone marrow-derived cells, which are important contributors in renal interstitial fibrosis. In this study, we tested the effect of a new STAT3 inhibitor, BP-1-102, on monocyte-to-fibrocyte transition and the progression of renal interstitial fibrosis. We tested the effect of BP-1-102 in a mouse model of unilateral ureteral obstruction in vivo and IL-33-treated bone marrow-derived monocytes in vitro. BP-1-102 treatment alleviated renal interstitial fibrosis, reduced collagen deposition and extracellular matrix protein production, inhibited inflammatory cell infiltration, suppressed the percentage of CD45+ PDGFRβ+, CD45+ CD34- Col I+ and CD45+ CD11b+ Col I+ cells within the obstructed kidney and reduced the mRNA levels of the proinflammatory and profibrotic cytokines IL-1β, TGF-β, TNF-α, ICAM-1, and CXCL16. In vitro, BP-1-102 inhibited the IL-33-induced phenotypic transition into fibroblast precursors in bone marrow-derived monocytes, marked by reduced CD45+ CD34- Col I+ and CD45+ CD11b+ Col I+ cell percentage. Our results indicate a potential mechanism by which the STAT3 inhibitor BP-1-102 inhibits bone marrow-derived monocyte transition into fibroblast precursors in an IL-33/STAT3-dependent manner and thereby alleviates renal interstitial fibrosis.
|
Authors | Fengge Zhu, Xueyuan Bai, Quan Hong, Shaoyuan Cui, Xu Wang, Fengjun Xiao, Jin Li, Li Zhang, Zheyi Dong, Yong Wang, Guangyan Cai, Xiangmei Chen |
Journal | Journal of immunology (Baltimore, Md. : 1950)
(J Immunol)
Vol. 203
Issue 10
Pg. 2644-2654
(11 15 2019)
ISSN: 1550-6606 [Electronic] United States |
PMID | 31591147
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2019 by The American Association of Immunologists, Inc. |
Chemical References |
- Aminosalicylic Acids
- BP-1-102
- Il33 protein, mouse
- Interleukin-33
- STAT3 Transcription Factor
- Stat3 protein, mouse
- Sulfonamides
|
Topics |
- Adaptation, Physiological
(drug effects)
- Aminosalicylic Acids
(pharmacology)
- Animals
- Bone Marrow
(metabolism)
- Cells, Cultured
- Disease Models, Animal
- Fibroblasts
(metabolism)
- Fibrosis
- Interleukin-33
(metabolism, pharmacology)
- Kidney
(pathology)
- Male
- Mice
- Mice, Inbred C57BL
- Monocytes
(metabolism)
- STAT3 Transcription Factor
(antagonists & inhibitors)
- Sulfonamides
(pharmacology)
- Ureteral Obstruction
(metabolism)
|